Simple blood test may replace spinal taps for Alzheimer's diagnosis

NCT ID NCT07717567

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study is testing whether proteins in the blood can accurately diagnose Alzheimer's disease and predict how quickly it will progress. Researchers will follow 2,000 adults with memory complaints for five years, collecting annual blood samples. The goal is to find a less invasive and cheaper alternative to current diagnostic methods like spinal taps and brain scans.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple blood test to diagnose Alzheimer's disease and predict its progression, replacing more invasive procedures.
What could go wrong
This is an observational study, not a treatment trial. The biomarkers may not prove accurate enough for widespread clinical use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • IRCCS Ospedale San Raffaele - Cognitive Disorders and Dementia Center (CDCD)

    RECRUITING

    Milan, Milano, 20132, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.